TRIM21 attenuates renal carcinoma lipogenesis and malignancy by regulating SREBF1 protein stability
Abstract Background Metabolic reprogramming is a hallmark of various cancers. Targeting metabolic processes is a very attractive treatment for cancer. Renal cell carcinoma (RCC) is a type of metabolic disease, and the lipidomic profile of RCC is significantly altered compared with that of healthy ti...
Uloženo v:
| Hlavní autoři: | , , , , , , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BMC
2023-01-01
|
| Edice: | Journal of Experimental & Clinical Cancer Research |
| Témata: | |
| On-line přístup: | https://doi.org/10.1186/s13046-022-02583-z |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|